Congratulations to Dr. Sarah Collard in the Department of Psychology, Dr. Pramod Regmi in the Department of Nursing Science and FHSS Visiting Professor Katherine Barnard-Kelly on their publication: ‘Exercising with an automated insulin delivery system: qualitative insight into the hopes and expectations of people with type 1 diabetes’ [1]. This paper in Practical Diabetes is a joint publication with several North American scholars.
The authors of this qualitative paper distilled three themes related to the benefits of automated insulin delivery systems: (a) more freedom and spontaneity in the individual’s ability to exercise; (b) relief
from worry of hypoglycaemia as a result of exercise; (c) removing the ‘guesswork’ of adjusting insulin for exercise, as well as two further themes relating to potential concerns with regard to safely exercising while wearing an automated insulin delivery system.
Well done!
Prof. Edwin van Teijlingen
CMMPH
Reference:
- Collard, S.S., Regmi, P.R., Hood, K.K., Laffel, L., Weissberg-Benchell, J., Naranjo, D., Barnard-Kelly, K. (2020) Exercising with an automated insulin delivery system: qualitative insight into the hopes and expectations of people with type 1 diabetes, Practical Diabetes 2020; 37(1): 19–23
Three successful cross-faculty Health-Psychology collaborations
Hat-trick of new diabetes papers
Congratulations to Dr. Pramod Regmi
New collaborative Nepal paper










Join the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease